Archean Chemical Industries (ACI.BO) Earnings Analysis
Archean Chemical Industries (ACI.BO) next reports earnings on 2026-07-30, consensus EPS 2.5 INR. Last quarter (2026-05-11) it missed with EPS 1.1 INR vs 4.65 INR est (-76.3%). It has beaten estimates in 0/6 recent quarters (0%). Trailing P/E 64.14.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ACI.BO next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | 2.5 INR |
| Revenue estimate | 3.21B |
ACI.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | 1.1 INR | 4.65 INR | -76.3% | Miss |
| 2026-02-04 | 1.9 INR | 2.8 INR | -32.1% | Miss |
| 2025-07-28 | 3.26 INR | 4.05 INR | -19.5% | Miss |
| 2025-02-07 | 3.88 INR | 4.6 INR | -15.7% | Miss |
| 2024-11-08 | 4.5 INR | 5.1 INR | -11.8% | Miss |
| 2024-08-02 | 3.63 INR | 4.65 INR | -21.9% | Miss |
Beat rate: 0/6 (0%) over reported quarters with consensus data.
ACI.BO valuation and analyst view
| Trailing P/E | 64.14 |
|---|---|
| Trailing EPS | 8.955 INR |
| Price / book | 3.41 |
| Dividend yield | 0.45% |
| Market cap | 68.56B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Archean Chemical Industries (ACI.BO)'s next earnings date?
Archean Chemical Industries is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 2.5 INR and revenue estimate of 3.21B.
Did ACI.BO beat earnings last quarter?
In its 2026-05-11 report, ACI.BO posted EPS of 1.1 INR versus a 4.65 INR estimate — a miss of 76.3%.
What is ACI.BO's earnings track record?
Over the last 6 reported quarters with consensus data, ACI.BO beat estimates 0 times (0%).
What is ACI.BO's current P/E ratio and EPS?
ACI.BO trades at a trailing P/E of 64.14 on trailing EPS of 8.954737223265488 INR.
What do analysts rate ACI.BO?
ACI.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.